These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2336124)

  • 1. [1992: pills without limits?].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1990 Apr; 134(16):821-7. PubMed ID: 2336124
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of therapeutic equivalence in drug registration and control.
    Idänpään-Heikkilä J
    Ann Clin Res; 1974; 6(0):suppl 11:71-8. PubMed ID: 4850672
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug control within the EEC II: good possibilities for Sweden].
    Strandberg K
    Lakartidningen; 1992 Jan; 89(4):178-9. PubMed ID: 1734147
    [No Abstract]   [Full Text] [Related]  

  • 4. [Registration and distribution of veterinary drugs up to and after 1992].
    Frens J
    Tijdschr Diergeneeskd; 1990 Jan; 115(1):22-6. PubMed ID: 2305380
    [No Abstract]   [Full Text] [Related]  

  • 5. [EURO-Medicines: a European program for bringing into agreement public health policies on drugs].
    Calamo-Specchia F; Bucci R; Folino-Gallo P
    Ann Ig; 1998; 10(5-6):405-12. PubMed ID: 10052204
    [No Abstract]   [Full Text] [Related]  

  • 6. European prices of newly launched reimbursable pharmaceuticals--a pilot study.
    Martikainen J; Kivi I; Linnosmaa I
    Health Policy; 2005 Nov; 74(3):235-46. PubMed ID: 16226136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the pharmaceutical industry in preventing drug abuse.
    Skinner WJ
    Am J Pharm Sci Support Public Health; 1970; 142(4):184-8. PubMed ID: 5514567
    [No Abstract]   [Full Text] [Related]  

  • 8. [European registration of drugs; consequences for prescriber and patient].
    Lekkerkerker JF; Broekmans AW
    Ned Tijdschr Geneeskd; 1997 Jul; 141(29):1446. PubMed ID: 9542874
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drugs after 1992; a comparison with yet many unknowns].
    Boer EJ
    Ned Tijdschr Geneeskd; 1990 Sep; 134(38):1863-7. PubMed ID: 2215761
    [No Abstract]   [Full Text] [Related]  

  • 10. [Is openness in the drug market possible?].
    Dölle W; Schwabe U
    Internist (Berl); 1986 Jan; 27(1):21-31. PubMed ID: 3514513
    [No Abstract]   [Full Text] [Related]  

  • 11. Vulnerable points in the U.S. drug-distribution system.
    Shepherd M
    Manag Care; 2004 Mar; 13(3 Suppl):25-9. PubMed ID: 15074167
    [No Abstract]   [Full Text] [Related]  

  • 12. Transparency of EU medicines agencies.
    Kopp C
    Prescrire Int; 2003 Aug; 12(66):156. PubMed ID: 12908499
    [No Abstract]   [Full Text] [Related]  

  • 13. [New pharmaceutical legislation in Italy and Federal Republic of Germany in relation to European Economic Community directives].
    Cavatorta L
    Boll Chim Farm; 1979 Mar; 118(3):144-62. PubMed ID: 475906
    [No Abstract]   [Full Text] [Related]  

  • 14. Rationale drug therapy: reasons for failure and suggestions for its implementation.
    Mathur GP; Kushwaha KP; Mathur S
    Indian Pediatr; 1993 Jun; 30(6):815-8. PubMed ID: 7726879
    [No Abstract]   [Full Text] [Related]  

  • 15. Substandard and counterfeit medicines.
    Rassool GH
    J Adv Nurs; 2004 May; 46(3):338-9. PubMed ID: 15119344
    [No Abstract]   [Full Text] [Related]  

  • 16. Future European health care: cost containment, health care reform and scientific progress in drug research.
    Emilien G
    Int J Health Plann Manage; 1997; 12(2):81-101. PubMed ID: 10173136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Too many drugs?
    Halberstam MJ
    Forum Med; 1979 Mar; 2(3):170-6 concl. PubMed ID: 10316794
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmaceutical specialities: definitions and rules for manufacturing and marketing in Italy].
    Germani C; Montanari L; Petraroja A
    Boll Chim Farm; 1979 Mar; 118(3):135-43. PubMed ID: 475905
    [No Abstract]   [Full Text] [Related]  

  • 19. [Registration of veterinary drugs: order or chaos?].
    Sybesma W
    Tijdschr Diergeneeskd; 1993 May; 118(9):308-9. PubMed ID: 8488491
    [No Abstract]   [Full Text] [Related]  

  • 20. [Increased commercial financing of national Medical Product Agencies within the EU].
    Ramel B
    Lakartidningen; 2003 Jan; 100(5):338-9. PubMed ID: 12607381
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.